Lifecore Biomedical Inc (LFCR)

Lifecore Biomedical Inc. is a healthcare company listed on NASDAQ as common stock. Through its subsidiaries, it operates as a contract development and manufacturing organization serving customers in the United States, Belgium, the Netherlands, and other international markets. The company supports the development and production of sterile injectable pharmaceutical and medical device products, including aseptic fill-finish work for syringes, vials, and cartridges. It also manufactures pharmaceutical-grade hyaluronic acid for bulk use and for inclusion in injectable formulations used in areas such as ophthalmic and orthopedic care. In addition, Lifecore provides development services that include analytical methods, formulation work, sterile filtration, scale-up activities, pilot and stability studies, process validation, and materials for clinical studies. The company was founded in 1965 and is headquartered in Chaska, Minnesota; it adopted the Lifecore Biomedical name in November 2022.

Jump between the core stock analysis sections, valuation data, fair value models, technical outlook, and FAQ.